Alt is also Investigator, Howard Hughes Medical Inst., Charles A. Alt, Ph.D., member of the National Academy of Sciences, Professor, Harvard Medical Schoolĭr. Frederick Alt Harvard Medical School, Boston, MAįrederick W.Cory Abate-Shen Columbia University, New York, NYĬory Abate-Shen, PhD, Professor, Director of Research, Department of Pathology, Associate Director, Herbert Irving Comprehensive Cancer Center, Columbia University, NY.His research interests range from molecular and cellular biology to clinical investigations and include signal transduction, cell cycle, cellular senescence, anticancer therapeutics with emphasis on translation of basic science into new anticancer strategies Recently, he extended the study of signal transduction pathways from cancer to aging, revealing potential targets for slowing down aging and age-related diseases. He is Associate Editor of Cancer Res, Cell Death Differ, Cancer Biol Ther, Autophagy, Int J Cancer, Am J Pathology, PLOS ONE and Editor-in-Chief of Cell Cycle. Blagosklonny is author of over 200 articles in peer-reviewed journals. Blagosklonny, M.D., Ph.D., Professor, Roswell Park Comprehensive Cancer Center, Buffalo, NYĭr.

Blagosklonny Roswell Park Comprehensive Cancer Center, Buffalo, NY His area of general research interest includes drug discovery, gene discovery, molecular targets for cancer treatment. He is co-founder and Chief Scientific Officer of Cleveland BioLabs, Inc. His academic degrees in experimental oncology and molecular biology were received in former USSR from National Cancer Center and Moscow State University. Gudkov, PhD, DSci, Professor and Garman Family Chair in Cell Stress Biology, Senior Vice President for Basic Research of Roswell Park Comprehensive Cancer Center (RPCI), Buffalo, NY. Gudkov Roswell Park Comprehensive Cancer Center, Buffalo, NYĪndrei V.

Tor bridge high academy in the bronx